Health Canada’s Environmental and Radiation Health Sciences Directorate is undertaking a review of the Radiation Emitting Devices Act (REDA), with a view towards modernizing the legislation and identifying gaps and irritants in the legislative coverage for radiation emitting devices that are sold, leased or imported in Canada.
The Department is seeking your perspectives with respect to potential impacts of changes under consideration for REDA and furthermore encourages you to identify current or foreseen challenges
posed by the existing statute, in the context of an emerging technology environment. Consult the
Proposed modernization of the Radiation Emitting Devices Act of the proposed amendments.
REDA focuses on radiation safety risks and governs the sale (including re-sale), lease, advertising and importation of radiation emitting devices in Canada. Radiation emitting devices are those that emit radiation in the form of electromagnetic energy (e.g. x-rays, microwaves, radiofrequency waves, infrared, visible light and ultraviolet light) or acoustical energy (e.g. sound and infra/ultrasound). Devices that fall under REDA can be categorized as medical devices (e.g. medical x-ray and ultrasound equipment), consumer products (e.g. laser pointers), or industrial/commercial products (e.g. airport security screening equipment, anti-theft devices and tanning beds).
In view of technological advances, increasing globalization, and the significant increase in the number and types of radiation emitting devices imported, leased or sold in Canada, it is important that legislation reflects modern and future radiation emitting device contexts. This includes consideration of alignment with international partners and comparable domestic legislation.
As any proposed amendments to REDA could have an impact on you as a stakeholder, we are interested in hearing your perspectives with respect to changes under consideration by the Department. We would furthermore like to hear if there are other considerations or challenges that exist under the current Act or alternatively, foreseen challenges in the context of emerging technology and trends.
A 60-day consultation has been launched and takes place from July 13, 2020 to September 11, 2020. Submit your comments or concerns to: hc.erhsdgeneral-dssergenerale.sc@canada.ca.
More information can be found on the Consultations here.
Contact us
Office of Science Policy, Liaison and Coordination
Environmental and Radiation Health Sciences Directorate
Healthy Environments and Consumer Safety Branch.
269 Laurier Avenue West
Mail Stop 4908D
Ottawa, Ontario
Canada
K1A 0K9